 NORCROSS, Ga., Sept. 09, 2021 GLOBE NEWSWIRE -- Galectin Therapeutics Inc. NASDAQ: GALT, the leading developer of therapeutics that target galectin proteins, today announced the Companys management will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The virtual conference will take place from September 1315, 2021. In addition to the presentation, management will conduct 1-on-1 meetings with investors. For more information on the conference or to register, visit: HCW Events. 